Search Count: 16
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-Benzyl-4-Chloro-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, PE4, A1IBV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-26
Ligands: EDO, PE4, A1IBV
 |
N-Terminal Bromodomain Of Human Brd4 With (5-(4-Chloro-1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, A1IB5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-26
Ligands: EDO, A1IB5
 |
N-Terminal Bromodomain Of Human Brd4 With I-Bet567
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2022-12-14 Classification: TRANSCRIPTION Ligands: AKQ, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-12-14
Ligands: AKQ, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-3-Methyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, P4M, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-11-30
Ligands: EDO, P4M, MES
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-7-((R)-1,2-Dihydroxyethyl)-1,3-Dimethyl-5-(1-Methyl-1H-Pyrazol-4-Yl)-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, 7PE, P4X |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-11-30
Ligands: EDO, 7PE, P4X
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, PE4, P0U |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-11-30
Ligands: EDO, PE4, P0U
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, PE4, P3R |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-11-30
Ligands: EDO, PE4, P3R
 |
Bromodomain Of Human Taf1 (2) With Naphthyridinone Compound
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2021-10-13 Classification: TRANSCRIPTION Ligands: 5LV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: 5LV
 |
C-Terminal Bromodomain Of Human Brd2 With Gsk973
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2020-10-21 Classification: TRANSCRIPTION Ligands: EDO, 1PG, QC8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-10-21
Ligands: EDO, 1PG, QC8
 |
Human Brd2 C-Terminal Bromodomain With 2-((4-Acetyl-3-Cyclopropyl-3,4-Dihydroquinoxalin-1(2H)-Yl)Methyl)Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2019-01-30 Classification: TRANSCRIPTION Ligands: PEG, EDO, D7Q |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-01-30
Ligands: PEG, EDO, D7Q
 |
Human Brd2 C-Terminal Bromodomain With (S)-5-(1-Acetyl-2-Cyclopropyl-4-(2-(Hydroxymethyl)Benzyl)-1,2,3,4-Tetrahydroquinoxalin-6-Yl)Pyrimidine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2019-01-30 Classification: TRANSCRIPTION Ligands: EDO, MES, D7H |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-01-30
Ligands: EDO, MES, D7H
 |
Human Brd2 C-Terminal Bromodomain With (S)-1-(2-Cyclopropyl-4-(2-(Hydroxymethyl)Benzyl)-6-(1,2,3,6-Tetrahydropyridin-4-Yl)-3,4-Dihydroquinoxalin-1(2H)-Yl)Ethanone
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2019-01-30 Classification: TRANSCRIPTION Ligands: EDO, D7B, PEG, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-01-30
Ligands: EDO, D7B, PEG, MES
 |
Bromodomain Of Human Brpf1 With N-1,3-Dimethyl-6-2R-2- Methylpiperazin-1-Yl-2-Oxo-2,3-Dihydro-1H-1,3-Benzodiazol-5-Yl-2- Methoxybenzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2016-07-06 Classification: TRANSCRIPTION Ligands: LF1 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-07-06
Ligands: LF1
 |
Bromodomain Of Human Brpf1 With N-1,3-Dimethyl-6-2R-2- Methylpiperazin-1-Yl-2-Oxo-2,3-Dihydro-1H-1,3-Benzodiazol-5-Yl-N- Ethyl-2-Methoxybenzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2016-07-06 Classification: TRANSCRIPTION Ligands: 8VI, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-07-06
Ligands: 8VI, EDO
 |
N-Terminal Bromodomain Of Human Brd4 With 1,3-Dimethyl-2-Oxo-2,3- Dihydro-1H-1,3-Benzodiazole-5-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2014-09-17 Classification: TRANSCRIPTION Ligands: DMS, EDO, V1T |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-09-17
Ligands: DMS, EDO, V1T
 |
Bromodomain Of Human Brpf1 With N-1,3-Dimethyl-2-Oxo-6-(Piperidin-1- Yl)-2,3-Dihydro-1H-1,3-Benzodiazol-5-Yl-2-Methoxybenzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2014-09-17 Classification: TRANSCRIPTION Ligands: EDO, 9F9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-09-17
Ligands: EDO, 9F9